Nazım Can Demircan

16PUBLICATIONS
47CO-AUTHORS
Molecular targetsNutrigenomics and personalised nutritionMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 19, 2026
Efficacy and safety of sacituzumab govitecan in hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.

|Jun 10, 2026
Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study.

|May 23, 2026
Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH score.

|May 09, 2026
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease: A Systematic Review and Meta-Analysis of Clinical Trials and Real-World Evidence.

|Jan 28, 2026
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab.

Erkam Kocaaslan, Ali Kaan Güren, Fırat Akagündüz

|Oct 06, 2025
Prognostic implications of cancer-associated fibroblasts and desmoplastic reaction in stage III colon cancer risk groups.

Nazım Can Demircan, Mehmet Fatih Tekin, Tuğba Akın Telli

Pageof 3

Frequent Collaborators

9 joint publications

Tuğba Akın Telli

6 joint publications

Tugba Basoglu Tuylu

5 joint publications

Ozkan Alan

5 joint publications

Ozlem Ercelep